STUELPNAGEL JOHN R sold 5.7% of their position (20K shares) of 10X GENOMICS, INC. on the open market
Open‑market sale worth $1.24M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/8/2026ACC: 0001610717-26-000405
-20K
Net shares
Net seller
$1.24M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
20K disposed
Non-Derivative Transactions3
Class A Common Stock
Direct
Shares
−7.01K
Price / share
$60.66
Trade value
$425.33K
% of position
2.0%
9/3/2026
348.44K→341.42K
Class A Common Stock
Direct
Shares
−6.81K
Price / share
$62.11
Trade value
$423.21K
% of position
2.0%
9/3/2026
341.42K→334.61K
Class A Common Stock
Direct
Shares
−6.17K
Price / share
$62.61
Trade value
$386.53K
% of position
1.8%
9/3/2026
334.61K→328.44K
Total
Net shares
−20K
Net value
-$1.24M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 9/3/2026 | S · Sale | −7.01K | $60.66 | $425.33K | 2.0% | 348.44K | 341.42K |
| Class A Common Stock Direct | 9/3/2026 | S · Sale | −6.81K | $62.11 | $423.21K | 2.0% | 341.42K | 334.61K |
| Class A Common Stock Direct | 9/3/2026 | S · Sale | −6.17K | $62.61 | $386.53K | 1.8% | 334.61K | 328.44K |
| Total | −20K | -$1.24M | ||||||
Derivative Transactions0
No derivative transactions reported